Showing posts with label in combination with an aromatase inhibitor (AI) as initial endocrine-based therapy. Show all posts
Showing posts with label in combination with an aromatase inhibitor (AI) as initial endocrine-based therapy. Show all posts
Wednesday, March 21, 2018

Lilly Receives Additional FDA Approval for Verzenio (abemaciclib), as Initial Treatment for Advanced Breast Cancer

›
In continuation of my update on  Abemaciclib Eli Lilly and Company  announced the U.S. Food and Drug Administration (FDA) has ap...